Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal
Key PointsAn executive at Palvella Therapeutics reported selling 4,302 common shares for approximately $508,000 on March 18, 2026...
Nasdaq News: Markets·23d ago